Eric F Egelund, Ph.D., Pharm.D.
Clinical Assistant Professor
Department:
Pharmacotherapy & Translational Research
Business Phone:
(904) 244-9876
Business Email:
eegelund@ufl.edu
About Eric F Egelund
After completing his Pharm.D. at the University of Florida College of Pharmacy, Dr. Egelund enrolled in the Ph.D. program at the University of Florida. Dr. Egelund completed his graduate studies in the Department of Pharmacotherapy and Translational Research under the mentorship of Dr. Charles Peloquin, director of the Infectious Disease Pharmacokinetics Laboratory (IDPL) in Gainesville. Currently Dr. Egelund is a Clinical Assistant Professor at the College of Pharmacy’s Jacksonville campus. In addition to this role Dr. Egelund works part-time at Walgreens and volunteers at HIV clinics when time permits.
Research Profile
Dr. Egelund’s primary research interest is the pharmacokinetics of infectious disease agents, specifically those used for the treatment of tuberculosis, non-tuberculosis mycobacteria (NTM), and HIV. Additionally, Dr. Egelund has an interest in interprofessional education, in particular, utilizing simulations to prevent medication errors.
Publications
2021
Impact of supplemental individual verbal defense on confidence, engagement, and performance in a team-based learning therapeutics course.
Currents in pharmacy teaching & learning.
13(2):152-158
[DOI] 10.1016/j.cptl.2020.09.010.
[PMID] 33454072.
2020
“Pet Nemo’s Pills”: The Last Loophole in Antimicrobial Stewardship?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
70(1):177-179
[DOI] 10.1093/cid/ciz388.
[PMID] 31074491.
2020
Ciprofloxacin/dexamethasone precipitate formation in the ear canal of a paediatric patient.
BMJ case reports.
13(7)
[DOI] 10.1136/bcr-2020-234290.
[PMID] 32616534.
2019
A Simulated Approach to Fostering Competency in End-of-Life Care Among Pharmacy Students.
American journal of pharmaceutical education.
83(4)
[DOI] 10.5688/ajpe6904.
[PMID] 31223159.
2019
Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?
Pharmacotherapy.
39(5):576-598
[DOI] 10.1002/phar.2246.
[PMID] 30860610.
2019
Intravenous and Oral Posaconazole Pharmacokinetics in a Five-Year-Old With Mucor: A Case Report and Review of the Literature.
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.
24(6):528-533
[DOI] 10.5863/1551-6776-24.6.528.
[PMID] 31719815.
2018
Tenofovir Alafenamide for the Treatment of Chronic Hepatitis B Monoinfection.
Pharmacotherapy.
38(10):1051-1057
[DOI] 10.1002/phar.2174.
[PMID] 30120841.
2018
Using interprofessional medication management simulations to impact student attitudes toward teamwork to prevent medication errors.
Currents in pharmacy teaching & learning.
10(7):982-989
[DOI] 10.1016/j.cptl.2018.04.010.
[PMID] 30236437.
2017
Teaching End-of-Life Care Using Interprofessional Simulation.
The Journal of nursing education.
56(4):205-210
[DOI] 10.3928/01484834-20170323-03.
[PMID] 28383743.
2016
A HAART-Breaking Review of Alternative Antiretroviral Administration: Practical Considerations with Crushing and Enteral Tube Scenarios.
Pharmacotherapy.
36(11):1145-1165
[DOI] 10.1002/phar.1835.
[PMID] 27636237.
2016
ISONIAZID AND RIFAMPIN PHARMACOKINETICS IN TWO ASIAN ELEPHANTS (ELEPHAS MAXIMUS) INFECTED WITH MYCOBACTERIUM TUBERCULOSIS.
Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.
47(3):868-871
[PMID] 27691967.
View on:
PubMed
2016
Rifapentine for the treatment of latent tuberculosis.
Expert review of clinical pharmacology.
9(10):1253-1261
[DOI] 10.1080/17512433.2016.1222270.
[PMID] 27545595.
2015
Medications and monitoring in nontuberculous mycobacteria infections.
Clinics in chest medicine.
36(1):55-66
[DOI] 10.1016/j.ccm.2014.11.001.
[PMID] 25676519.
2015
Optimizing the clinical pharmacology of tuberculosis medications.
Clinical pharmacology and therapeutics.
98(4):387-93
[DOI] 10.1002/cpt.180.
[PMID] 26138226.
2015
Population pharmacokinetics of rifampin in the treatment of Mycobacterium tuberculosis in Asian elephants.
Journal of veterinary pharmacology and therapeutics.
38(2):137-43
[DOI] 10.1111/jvp.12156.
[PMID] 25236765.
2015
Voriconazole monitoring in children with invasive fungal infections.
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.
20(1):17-23
[DOI] 10.5863/1551-6776-20.1.17.
[PMID] 25859166.
2014
CYP2C19 polymorphisms and therapeutic drug monitoring of voriconazole: are we ready for clinical implementation of pharmacogenomics?
Pharmacotherapy.
34(7):703-18
[DOI] 10.1002/phar.1400.
[PMID] 24510446.
2014
Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers.
The Journal of antimicrobial chemotherapy.
69(4):1079-85
[DOI] 10.1093/jac/dkt483.
[PMID] 24343893.
2014
Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis.
Antimicrobial agents and chemotherapy.
58(8):4904-10
[DOI] 10.1128/AAC.01730-13.
[PMID] 24841270.
2014
The pharmacokinetics of a single oral or rectal dose of concurrently administered isoniazid, rifampin, pyrazinamide, and ethambutol in Asian elephants (Elephas maximus).
Journal of veterinary pharmacology and therapeutics.
37(5):472-9
[DOI] 10.1111/jvp.12119.
[PMID] 24684601.
2013
Posaconazole pharmacokinetics in a 2-year-old boy with rhino-cerebral-orbital zygomycosis.
Pharmacotherapy.
33(1):e1-8
[DOI] 10.1002/phar.1172.
[PMID] 23307552.
2012
Editorial commentary: pharmacokinetic variability and tuberculosis treatment outcomes, including acquired drug resistance.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
55(2):178-9
[DOI] 10.1093/cid/cis366.
[PMID] 22467672.
2012
The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
American journal of respiratory and critical care medicine.
186(6):559-65
[DOI] 10.1164/rccm.201204-0682OC.
[PMID] 22744719.
2011
Blood pressure lowering in patients with diabetes–one level might not fit all.
Nature reviews. Cardiology.
8(1):42-9
[DOI] 10.1038/nrcardio.2010.182.
[PMID] 21079637.
2011
Population pharmacokinetics and its role in anti-tuberculosis drug development and optimization of treatment.
Current pharmaceutical design.
17(27):2889-99
[PMID] 21834766.
View on:
PubMed
Grants
Oct 2019
– Sep 2020
Interprofessional Opioid Patient Safety Training Across the Lifespan
Role: Co-Investigator
Funding: UF HEALTH SHANDS HOSPITAL
Education
Ph.D.
2014
·
University of Florida
Pharm.D.
2009
·
University of Florida
B.S.
1997
·
University of West Florida
Teaching Profile
Courses Taught
2015-2018,2020-2021
PHA5161L Pract Skills Lab I
2015-2021
PHA5103 Prin Pt Centered Care
2020-2021
PHA5222 Pharmacy Management
2018-2021
PHA5876C Pt Care 8 Complex Pts
2016-2019
PHA5132 Prin Drug Ther Indiv
2018
PHA5165L Prof Skills Lab V
2015,2018
PHA5907 Research in Phar Prac
2018
PHA5759 Advanced Pharmacy Practice Experience Readiness
2014-2018
PHA5841 HIV: Challeng and Trmnt
2016-2018,2021
PHA5162L Prac Skills Lab II
2015,2017
PHA5787 Pharmacotherapy 5
2015-2016
PHA5742C Pro Commun Pharm Prac
2014-2015
PHA5108L Pharmaceu Skls Lab 1
2015
PHA5788 Pharmacotherapy 6
2015
PHA5101 Dosage Forms 2
2014
PHA5784 Pharmacotherapy 4
2013
PHA5783 Pharmacotherapy 3
Contact Details
Phones:
- Business:
- (904) 244-9876
Emails:
- Business:
- eegelund@ufl.edu